Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1274 of 5804
-
Stem cell shot aims to seal Crohn's fistulas
Disease control Recruiting nowPerianal fistulas are in the forefront (42 to 72, 4%) of morbid complication of Crohn's disease, affecting nearly one- third of patients and complicating abscesses in 35-48% of cases. The current treatment is based on the combination of drainage (proctologic and surgical), and bi…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New shot could help diabetics shed pounds on top of existing meds
Disease control OngoingThis Phase II study is a randomized, parallel group, double blinded, placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes on stable GLP-1 RA therapy.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Silver shield for hips: new implant aims to stop infections
Disease control Recruiting nowThe aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indee…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study tackles stigma and shame to help people with HIV and addiction get healthy
Disease control Recruiting nowPeople living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing…
Phase: NA • Sponsor: Boston University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for kids with arthritis: drug trial launches
Disease control Recruiting nowThe purpose of this study is to assess plasma bimekizumab concentrations following subcutaneous (sc) bimekizumab administration.
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug combo aims to tackle tough lymphoma
Disease control TerminatedThis phase II trial tests the safety, side effects and effectiveness of epcoritamab and tazemetostat in treating patients with grade I-IIIa follicular lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory)…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Lakota diabetes study aims to turn tide with culturally grounded approach
Disease control Recruiting nowThe goal of this research is to evaluate a scientifically rigorous diabetes intervention, Together Overcoming Diabetes (TOD), that has been tailored to address the unique underlying risk and protective factors and social determinants of diabetes among American Indian/Alaska Nativ…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New scan could reveal how well immunotherapy is working
Diagnosis Recruiting nowThis is a multi-center, single-arm trial designed to evaluate the safety and imaging characteristics of 89Zr-Df-crefmirlimab in patients with locally advanced or metastatic solid tumours prior to and during PD-1 antibody therapy.
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Could a simple antibiotic course fight oral cancer from the inside?
Disease control Recruiting nowThe goal of this phase II single arm clinical study is to evaluate the effect of antibiotics (metronidazole) and oral chlorhexidine (CHX) in reducing the bacteria load within tumors of patients undergoing surgery for oral cancer.
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smart pump trial aims to tame tough diabetes cases
Disease control OngoingThe objective of this study is to evaluate whether the mylife CamAPS FX hybrid closed loop (HCL) system improves glycemic control and quality of life in type 1 diabetes (T1DM) patients with a chronic lack of glycemic control and with psychological problems. After screening visit…
Phase: NA • Sponsor: Jerzy Hohendorff • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study tests best antibiotic for superbug infections
Disease control Recruiting nowThe primary objective of the ADDICT study is to assess and compare the clinical efficacy of available options for antimicrobial therapy (new beta-lactam/beta-lactamase inhibitor combination, cefiderocol or older agents such as aminoglycosides and colistin) in unselected patients …
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New lidocaine shot to skull aims to stop migraines
Symptom relief Recruiting nowThe main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic …
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Radioactive drug targets tough lung cancers in early trial
Disease control OngoingThe study has 2 parts, Phase 1a and Phase 1b. The goal of Phase 1a is to gather safety, PK and initial efficacy data for 225Ac-ABD147 to better understand best doses for patients with small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) of the lung follow…
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
AI alerts in medical records aim to curb opioid overdoses
Disease control Recruiting nowThe goal of this cluster randomized clinical trial is to test a clinician-targeted behavioral nudge intervention in the Electronic Health Record (EHR) for patients who are identified by a machine-learning based risk prediction model as having an elevated risk for an opioid overdo…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill could cool menopause hot flashes without hormones
Symptom relief CompletedHot flashes are the most common reason women going through menopause seek medical attention. Hormone replacement therapy, or HRT, is most often prescribed to treat hot flashes. However, HRT can't be used by all women or for as long as may be needed. The goal of this study is to …
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a smartphone app and a coach help young sickle cell patients hurt less?
Symptom relief Recruiting nowThe study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs …
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Phone-Based group therapy aims to stop postpartum depression before it starts
Prevention OngoingThe goal of this clinical trial is to evaluate if a digital group intervention (named IMAGINE) can prevent depression in perinatal populations. The main questions it aims to answer are: Does IMAGINE engage cognitive behavioral therapy targets? Does IMAGINE lead to lower depressi…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy targets hard-to-treat blood cancers in early trial
Disease control Recruiting nowThis study is a Phase 1 dose-escalation and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV111. The study will enroll patients with relapsed/refractory large B-cell lymphoma (LBCL) and chronic lymphocytic leukemia (CLL).
Phase: PHASE1 • Sponsor: Umoja Biopharma • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a diabetes drug help heart shock patients?
Disease control OngoingCardiogenic shock represents a severe condition of heart pump dysfunction. Despite advances in medical management, the mortality rate for this condition remains high. Conventional treatments for cardiovascular diseases have several side effects that make their use impossible in p…
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New toolkit aims to stop mental health problems before they start in military airmen
Prevention Recruiting nowSub-clinical behavioral health services in the military are performed by BH technicians, who receive minimal training. Due to this, embedding more technicians in military units is unlikely to benefit service members. Giving technicians training in, and access to, evidence-based i…
Phase: NA • Sponsor: New York University • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC